MedTrace Logo

Adjunctive Psychotherapy for Perinatal Bipolar Disorder

NCT02402738 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2019-01-16

No results posted yet for this study

Summary

Bipolar disorder (BD) is a serious, disabling, and highly recurrent illness. The perinatal period dramatically increases risk for mood episodes in women with BD, but pregnancy complicates pharmacologic treatment decisions and efficacy. This study will be the first to systematically develop and pilot test an adjunctive psychosocial intervention to assist in treatment of BD during the high-risk perinatal period.

Conditions

Interventions

BEHAVIORAL

Interpersonal and Social Rhythm Therapy

BEHAVIORAL

Enhanced Treatment as Usual

Sponsors & Collaborators

  • Butler Hospital

    collaborator OTHER

  • Women and Infants Hospital of Rhode Island

    collaborator OTHER

  • The Miriam Hospital

    collaborator OTHER

  • Michigan State University

    collaborator OTHER

  • Brown University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2018-03-31
Completion
2018-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02402738 on ClinicalTrials.gov